Two Sigma Investments, LP Vaxxinity, Inc. Transaction History

Two Sigma Investments, LP

  • $41.1 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.43 - $4.24 $25,448 - $75,455
17,796 New
17,796 $40,000
Q3 2022

Nov 14, 2022
SELL
$1.64 - $2.48 $169,853 - $256,851
-103,569 Reduced 80.59%
24,947 $49,000
Q2 2022

Aug 15, 2022
BUY
$1.55 - $6.95 $199,199 - $893,186
128,516 New
128,516 $202,000

Others Institutions Holding VAXX

# of Institutions
9
Shares Held
469K
Call Options Held
0
Put Options Held
0
View Full List

About Vaxxinity, Inc.

VAXX Quotes by TradingView
  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email